Oregon Health & Science University, Portland, USA; VA Portland Health Care System, Portland, USA.
University of California San Francisco, San Francisco, USA.
Radiother Oncol. 2018 Dec;129(3):421-426. doi: 10.1016/j.radonc.2018.05.030. Epub 2018 Jun 12.
Artificial intelligence (AI) is emerging as a technology with the power to transform established industries, and with applications from automated manufacturing to advertising and facial recognition to fully autonomous transportation. Advances in each of these domains have led some to call AI the "fourth" industrial revolution [1]. In healthcare, AI is emerging as both a productive and disruptive force across many disciplines. This is perhaps most evident in Diagnostic Radiology and Pathology, specialties largely built around the processing and complex interpretation of medical images, where the role of AI is increasingly seen as both a boon and a threat. In Radiation Oncology as well, AI seems poised to reshape the specialty in significant ways, though the impact of AI has been relatively limited at present, and may rightly seem more distant to many, given the predominantly interpersonal and complex interventional nature of the specialty. In this overview, we will explore the current state and anticipated future impact of AI on Radiation Oncology, in detail, focusing on key topics from multiple stakeholder perspectives, as well as the role our specialty may play in helping to shape the future of AI within the larger spectrum of medicine.
人工智能(AI)正在成为一种具有变革现有行业能力的技术,其应用领域从自动化制造到广告、面部识别到完全自主运输。这些领域的每一项进步都使一些人将 AI 称为“第四次”工业革命[1]。在医疗保健领域,AI 正在成为许多学科的生产力和颠覆性力量。这在放射诊断学和病理学中最为明显,这些专业主要围绕医学图像的处理和复杂解释,AI 的作用越来越被视为既是福音,也是威胁。在放射肿瘤学中,AI 似乎也准备以重大的方式重塑该专业,尽管目前 AI 的影响相对有限,而且鉴于该专业主要是人际互动和复杂的介入性质,对许多人来说,它可能看起来更加遥远。在本篇综述中,我们将详细探讨 AI 对放射肿瘤学的当前状态和预期未来影响,重点关注来自多个利益相关者视角的关键主题,以及我们的专业可能在帮助塑造 AI 在更广泛的医学领域的未来方面所扮演的角色。